Kirkland & Ellis advised Suzhou Basecare Medical Corporation Limited (HKSE: 2170), an innovative platform of genetic testing solutions for assisted reproduction in China, in its $233 million global offering of H-shares and listing on the Hong Kong Exchanges and Clearing Limited. The listing took place on February 8, 2021.
Read more in Suzhou Basecare Medical’s listing document
The Kirkland team was led by capital markets partner Mengyu Lu.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
